GILEAD SCIENCES INC's ticker is and the CUSIP is 375558903. A total of 10 filers reported holding GILEAD SCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,829,728 | -50.3% | 171,200 | -48.9% | 0.04% | -48.2% |
| Q2 2023 | $25,833,864 | -16.9% | 335,200 | -10.5% | 0.08% | -25.9% |
| Q1 2023 | $31,088,859 | -33.9% | 374,700 | -31.6% | 0.11% | +2.8% |
| Q4 2022 | $47,020,045 | +18.0% | 547,700 | -15.2% | 0.11% | +39.7% |
| Q3 2022 | $39,858,000 | -3.7% | 646,100 | -3.5% | 0.08% | +20.0% |
| Q2 2022 | $41,369,000 | -46.2% | 669,300 | -48.2% | 0.06% | -14.5% |
| Q1 2022 | $76,887,000 | -2.5% | 1,293,300 | +19.1% | 0.08% | +20.6% |
| Q4 2021 | $78,869,000 | -15.7% | 1,086,200 | -18.9% | 0.06% | -37.6% |
| Q3 2021 | $93,515,000 | +73.6% | 1,338,800 | +71.1% | 0.10% | +55.4% |
| Q2 2021 | $53,883,000 | +14.8% | 782,500 | +7.8% | 0.06% | -5.8% |
| Q1 2021 | $46,921,000 | -10.1% | 726,000 | -18.9% | 0.07% | -23.3% |
| Q4 2020 | $52,183,000 | -28.7% | 895,700 | -22.6% | 0.09% | -60.9% |
| Q3 2020 | $73,142,000 | -72.2% | 1,157,500 | -66.1% | 0.23% | -81.0% |
| Q2 2020 | $262,873,000 | +89.5% | 3,416,600 | +84.1% | 1.21% | +7.8% |
| Q1 2020 | $138,717,000 | +1391.7% | 1,855,500 | +1196.6% | 1.12% | +1685.7% |
| Q4 2019 | $9,299,000 | -3.9% | 143,100 | -6.2% | 0.06% | -19.2% |
| Q3 2019 | $9,672,000 | +5.2% | 152,600 | +12.1% | 0.08% | -6.0% |
| Q2 2019 | $9,195,000 | -53.5% | 136,100 | -55.3% | 0.08% | -62.4% |
| Q1 2019 | $19,789,000 | -74.2% | 304,400 | -75.1% | 0.22% | -66.7% |
| Q4 2018 | $76,586,000 | +176.8% | 1,224,400 | +241.7% | 0.66% | +203.2% |
| Q3 2018 | $27,664,000 | +150.3% | 358,300 | +129.7% | 0.22% | +130.5% |
| Q2 2018 | $11,051,000 | -30.7% | 156,000 | -26.2% | 0.10% | -40.6% |
| Q1 2018 | $15,945,000 | -7.0% | 211,500 | -11.6% | 0.16% | +33.3% |
| Q4 2017 | $17,136,000 | -23.8% | 239,200 | -13.8% | 0.12% | -41.2% |
| Q3 2017 | $22,491,000 | +719.0% | 277,600 | +615.5% | 0.20% | +603.4% |
| Q2 2017 | $2,746,000 | -76.3% | 38,800 | -77.2% | 0.03% | -78.5% |
| Q1 2017 | $11,580,000 | +41.6% | 170,500 | +49.3% | 0.14% | +70.9% |
| Q4 2016 | $8,178,000 | +7.6% | 114,200 | +18.8% | 0.08% | -4.8% |
| Q3 2016 | $7,603,000 | -54.0% | 96,100 | -51.5% | 0.08% | -57.4% |
| Q2 2016 | $16,517,000 | +1.1% | 198,000 | +11.4% | 0.20% | -15.6% |
| Q1 2016 | $16,333,000 | -30.9% | 177,800 | -23.9% | 0.23% | -17.2% |
| Q4 2015 | $23,628,000 | +75.6% | 233,500 | +70.4% | 0.28% | +50.0% |
| Q3 2015 | $13,452,000 | -24.2% | 137,000 | -9.6% | 0.19% | -25.0% |
| Q2 2015 | $17,749,000 | +17.1% | 151,600 | -1.8% | 0.25% | +4.2% |
| Q1 2015 | $15,151,000 | +7.8% | 154,400 | +3.6% | 0.24% | +12.3% |
| Q4 2014 | $14,054,000 | +40054.3% | 149,100 | +29720.0% | 0.21% | +21100.0% |
| Q1 2014 | $35,000 | -96.4% | 500 | -96.1% | 0.00% | -93.3% |
| Q4 2013 | $962,000 | +9.3% | 12,800 | -8.6% | 0.02% | -11.8% |
| Q3 2013 | $880,000 | -21.9% | 14,000 | -36.4% | 0.02% | -39.3% |
| Q2 2013 | $1,127,000 | – | 22,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 963,700 | $67,314,000 | 1.98% |
| PURA VIDA INVESTMENTS, LLC | 150,000 | $10,478,000 | 0.32% |
| Capital Markets Trading UK LLP | 245,200 | $17,394,000 | 0.23% |
| GROUP ONE TRADING, L.P. | 1,338,800 | $93,515,000 | 0.10% |
| SIMPLEX TRADING, LLC | 757,000 | $52,331,000 | 0.05% |
| Marathon Trading Investment Management LLC | 4,000 | $279,000 | 0.02% |
| Maven Securities LTD | 5,400 | $377,000 | 0.01% |
| Allianz Asset Management GmbH | 70,900 | $4,952,000 | 0.00% |
| JPMORGAN CHASE & CO | 155,900 | $10,890,000 | 0.00% |
| CIBC WORLD MARKETS CORP | 2,000 | $140,000 | 0.00% |